Eledon Pharmaceuticals Inc (ELDN)
4.13
-0.14
(-3.28%)
USD |
NASDAQ |
Nov 14, 16:00
4.03
-0.10
(-2.42%)
After-Hours: 20:00
Eledon Pharmaceuticals Total Liabilities (Quarterly): 128.98M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 128.98M |
| March 31, 2024 | 5.999M |
| December 31, 2023 | 81.86M |
| September 30, 2023 | 4.734M |
| June 30, 2023 | 6.836M |
| March 31, 2023 | 7.514M |
| December 31, 2022 | 8.61M |
| September 30, 2022 | 8.493M |
| June 30, 2022 | 5.327M |
| March 31, 2022 | 5.06M |
| December 31, 2021 | 6.553M |
| September 30, 2021 | 6.422M |
| June 30, 2021 | 5.784M |
| March 31, 2021 | 7.811M |
| December 31, 2020 | 6.589M |
| September 30, 2020 | 171.08M |
| June 30, 2020 | 1.145M |
| March 31, 2020 | 1.975M |
| December 31, 2019 | 1.466M |
| September 30, 2019 | 1.852M |
| June 30, 2019 | 2.184M |
| Date | Value |
|---|---|
| March 31, 2019 | 3.522M |
| December 31, 2018 | 2.534M |
| September 30, 2018 | 1.603M |
| June 30, 2018 | 1.452M |
| March 31, 2018 | 1.619M |
| December 31, 2017 | 1.44M |
| September 30, 2017 | 2.40M |
| June 30, 2017 | 3.405M |
| March 31, 2017 | 2.467M |
| December 31, 2016 | 3.898M |
| September 30, 2016 | 6.464M |
| June 30, 2016 | 7.973M |
| March 31, 2016 | 6.303M |
| December 31, 2015 | 6.25M |
| September 30, 2015 | 5.708M |
| June 30, 2015 | 4.66M |
| March 31, 2015 | 5.754M |
| December 31, 2014 | 4.243M |
| September 30, 2014 | 5.372M |
| June 30, 2014 | 3.688M |
| December 31, 2013 | 87.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.145M
Minimum
Jun 2020
171.08M
Maximum
Sep 2020
24.85M
Average
6.553M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 120.48M |
| Shareholders Equity (Quarterly) | -8.501M |